IRIS
SANTAMATO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.819
EU - Europa 4.852
AS - Asia 3.863
SA - Sud America 531
Continente sconosciuto - Info sul continente non disponibili 456
AF - Africa 108
OC - Oceania 28
Totale 15.657
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.727
CN - Cina 1.343
IE - Irlanda 1.219
SG - Singapore 1.185
UA - Ucraina 834
RU - Federazione Russa 673
FR - Francia 574
SE - Svezia 497
BR - Brasile 410
IT - Italia 375
HK - Hong Kong 352
IN - India 237
VN - Vietnam 207
TR - Turchia 187
DE - Germania 161
GB - Regno Unito 149
FI - Finlandia 146
PK - Pakistan 73
PL - Polonia 48
CA - Canada 47
AR - Argentina 44
JP - Giappone 44
NL - Olanda 38
EG - Egitto 37
BD - Bangladesh 34
MX - Messico 32
IQ - Iraq 28
IR - Iran 28
BE - Belgio 24
CZ - Repubblica Ceca 24
AU - Australia 23
ES - Italia 19
ID - Indonesia 19
ZA - Sudafrica 19
EU - Europa 17
MY - Malesia 17
CO - Colombia 16
VE - Venezuela 16
TH - Thailandia 15
EC - Ecuador 14
SA - Arabia Saudita 13
CL - Cile 11
GR - Grecia 11
TW - Taiwan 11
KE - Kenya 10
PE - Perù 10
LY - Libia 9
RO - Romania 9
TN - Tunisia 8
UZ - Uzbekistan 8
JO - Giordania 7
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
CH - Svizzera 6
MA - Marocco 6
PH - Filippine 6
SI - Slovenia 6
LT - Lituania 5
NZ - Nuova Zelanda 5
RS - Serbia 5
AZ - Azerbaigian 4
BO - Bolivia 4
DZ - Algeria 4
ET - Etiopia 4
HU - Ungheria 4
NP - Nepal 4
PS - Palestinian Territory 4
GT - Guatemala 3
IL - Israele 3
MD - Moldavia 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BG - Bulgaria 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JM - Giamaica 2
KR - Corea 2
MM - Myanmar 2
PT - Portogallo 2
PY - Paraguay 2
SC - Seychelles 2
SM - San Marino 2
SY - Repubblica araba siriana 2
TL - Timor Orientale 2
UY - Uruguay 2
YE - Yemen 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
GA - Gabon 1
Totale 15.203
Salva come PNG Salva come JPEG
Città #
Dublin 1.218
San Jose 1.061
Jacksonville 579
Singapore 558
Dearborn 430
Ashburn 395
Chandler 391
Hong Kong 339
Nyköping 339
Nanjing 276
Beijing 275
Santa Clara 188
Wilmington 169
Lauterbourg 137
New York 136
Princeton 135
Council Bluffs 133
Nanchang 119
Dallas 107
San Mateo 94
Moscow 84
Ann Arbor 82
The Dalles 78
Ho Chi Minh City 71
Columbus 70
Los Angeles 68
Shenyang 56
Boardman 47
Helsinki 47
Hebei 44
Des Moines 42
Kunming 42
Tianjin 42
Seattle 40
Hanoi 38
Bari 37
Munich 33
Woodbridge 33
Guangzhou 32
Jiaxing 31
São Paulo 31
Jinan 29
Changsha 28
Ningbo 28
Pune 26
Hangzhou 25
Foggia 24
Milan 24
San Francisco 22
Shanghai 22
Zhengzhou 22
Warsaw 21
Brussels 19
London 18
Rome 18
Hilden 17
Houston 17
Belo Horizonte 16
Chennai 14
Boston 13
Brno 13
Brooklyn 13
Kraków 13
Lahore 13
Lanzhou 13
Paris 13
Rio de Janeiro 13
Stockholm 13
Ankara 12
Bengaluru 12
Flushing 12
Frankfurt am Main 12
Istanbul 12
Mexico City 12
Redwood City 12
Changchun 11
Ismailia 11
Kocaeli 11
Phoenix 11
Wuhan 11
Bangkok 10
Berlin 10
Chicago 10
Faisalabad 10
Haiphong 10
San Genesio Ed Uniti 10
Tokyo 10
Athens 9
Buenos Aires 9
Giza 9
Islamabad 9
Taizhou 9
Tripoli 9
Atlanta 8
Da Nang 8
Las Vegas 8
Norwalk 8
Nuremberg 8
Orem 8
Tashkent 8
Totale 8.953
Salva come PNG Salva come JPEG
Nome #
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial. 481
Approccio clinico e riabilitativo alla sindrome da conflitto subacromiale 212
Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review 199
Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis 165
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease. 164
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 161
Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication. 160
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. 159
The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. 155
VALUTAZIONE BAROPODOMETRICA IN PAZIENTI CON MORBO DI PARKINSON IN FASE INIZIALE,CONFRONTO CON GRUPPO DI CONTROLLO E E SUCCESSIVA VALUTAZIONE DOPO TRATTAMENTO RIABILITATIVO 154
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial. 154
Efficacia comparata tra laser Neodimio YAG e ultrasuoni nel trattamento della sindrome da conflitto sub acromiale 150
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. 150
Lifestyle-related factors in predementia and dementia syndromes. 149
L’attività fisica programmata nella prevenzione dei danni secondari nel bambino diabetico” 148
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 147
Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201 146
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 145
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. 143
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. 142
Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? 139
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. 138
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 137
SBOTE study: Extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial 135
Lipoproteins, vascular-related genetic factors, and human longevity. 134
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. 130
Dietary Fatty acids, age-related cognitive decline, and mild cognitive impairment 130
Progression to dementia in probable and possible mild cognitive impairment 129
Vascular risk factors, alcohol intake, and cognitive decline 129
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. 129
Anti-β-Amyloid Immunotherapy forAlzheimer's Disease: Focus on Bapineuzumab. 128
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease 128
Effect of botulinum toxin type A andmodified constraint-induced movement therapy on motor function of upper limb inchildren with obstetrical brachial plexus palsy 127
severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica 126
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 126
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 124
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature 124
Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: manual needle placement evaluated using ultrasonography. 123
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging 119
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity 118
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty. 117
Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome). 116
Lifestyle-related factors in predementia and dementia syndromes. 116
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 116
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms. 115
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults 114
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 114
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging 113
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease 113
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 113
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 113
Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study 112
Current and emerging treatments for amyotrophic lateral sclerosis. 111
Tau aggregation inhibitors: The future of Alzheimers pharmacotherapy? 110
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 110
L'ESERCIZIO ISOCINETICO 109
Higher total cholesterol, cognitive decline, and dementia. 108
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 108
Hypertension and mild cognitive impairment subtypes 106
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 104
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment 103
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial 103
Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review 103
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults. 102
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 101
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 101
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? 100
Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation 100
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease 99
Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study. 99
The role of the rehabilitation in subjects with Progressive Supranuclear Palsy: a narrative review 98
Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study. 97
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 97
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging 97
Postural and balance disorders in patients with Parkinson's disease: A prospective open-label feasibility study with two months of action observation treatment 97
Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries. 96
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 96
Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms 96
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. 95
Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report 95
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia? 94
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 94
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 94
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 94
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 93
Effect of intrathecal baclofen, botulinum toxin type A and arehabilitation programme on locomotor function after spinal cord injury: a casereport. 92
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 91
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 90
Safety and efficacy of incobotulinumtoxin A as a potential treatment for poststroke spasticity 89
Pulmonary rehabilitation for patients with bronchiectasis: case reports. 88
Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial 88
Current epidemiological approaches to the metabolic-cognitive syndrome. 87
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 87
AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study. 87
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. 86
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. 84
High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. 84
Post-stroke spasticity as a condition: a new perspective on patient evaluation 84
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 84
Intra-articular injection of botulinum toxin type A for shoulder pain in glenohumeral osteoarthritis: A case series summary and review of the literature 82
Totale 12.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.624
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022582 0 5 32 32 39 6 17 55 99 57 46 194
2022/20233.070 245 100 88 121 104 205 89 284 1.427 99 164 144
2023/2024584 53 25 25 25 61 238 20 41 7 8 9 72
2024/20252.249 131 21 40 92 57 295 246 122 663 104 234 244
2025/20263.952 244 324 403 542 159 183 856 411 292 276 102 160
2026/2027313 86 227 0 0 0 0 0 0 0 0 0 0
Totale 15.657